Sort   by:  
 Page size 
UnknownGermline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer.
Not available
S-EPMC4715968 | biostudies-literature
UnknownUnusual fcc-structured Ag10 kernels trapped in Ag70 nanoclusters.
Not available
S-EPMC6333236 | biostudies-literature
UnknownRisk of Pathological Upgrading and Up Staging among Men with Low Risk Prostate Cancer Varies by Race: Results from the National Cancer Database.
Not available
S-EPMC6513017 | biostudies-literature
UnknownMelanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer.
Not available
S-EPMC10813664 | biostudies-literature
UnknownPathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.
Not available
S-EPMC4042393 | biostudies-literature
UnknownReclassification rates are higher among African American men than Caucasians on active surveillance.
Not available
S-EPMC4275346 | biostudies-literature
UnknownInhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation.
Not available
S-EPMC6493227 | biostudies-literature
UnknownA Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines.
Not available
S-EPMC10813852 | biostudies-literature
UnknownVery-high-risk localized prostate cancer: definition and outcomes.
Not available
S-EPMC3945953 | biostudies-literature
UnknownSex-biased adaptive immune regulation in cancer development and therapy.
Not available
S-EPMC9307950 | biostudies-literature
Sort   by:  
 Page size